Last reviewed · How we verify
DEXMEDETOMIDINE HYDROCHLORIDE
DEXMEDETOMIDINE HYDROCHLORIDE is a drug. It is currently FDA-approved (first approved 1999).
At a glance
| Generic name | DEXMEDETOMIDINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1999 |
Approved indications
Common side effects
- Hypotension
- Respiratory Depression
- Bradycardia
- Hypertension
- Tachycardia
- Nausea
- Dry Mouth
- Hypoxia
- Bradypnea
- Anemia
- Arrhythmia
- Atrioventricular block
Key clinical trials
- Using Lidocaine or Dexmedetomidine to Help Control Blood Pressure Spikes From a Tourniquet During Knee Surgery (PHASE2)
- Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial) (PHASE2)
- PENG Block With Dexmedetomidine in Older Adults (NA)
- Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery (PHASE4)
- BXCL501 After Stress to Increase Recovery Success (PHASE2)
- Effect of Dexmedetomidine on Lung Protection in Elderly Patients Undergoing Laparoscopic Surgery for Colorectal Cancer (NA)
- Hypotensive Anesthesia for Orthognathic Surgery (PHASE4)
- Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status (PHASE3)
Patents
| Patent | Expiry | Type |
|---|---|---|
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| FDA Orange Book | Patents + exclusivity |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DEXMEDETOMIDINE HYDROCHLORIDE CI brief — competitive landscape report
- DEXMEDETOMIDINE HYDROCHLORIDE updates RSS · CI watch RSS
Frequently asked questions about DEXMEDETOMIDINE HYDROCHLORIDE
What is DEXMEDETOMIDINE HYDROCHLORIDE?
DEXMEDETOMIDINE HYDROCHLORIDE is a Small molecule drug.
When was DEXMEDETOMIDINE HYDROCHLORIDE approved?
DEXMEDETOMIDINE HYDROCHLORIDE was first approved on 1999.
What development phase is DEXMEDETOMIDINE HYDROCHLORIDE in?
DEXMEDETOMIDINE HYDROCHLORIDE is FDA-approved (marketed).
What are the side effects of DEXMEDETOMIDINE HYDROCHLORIDE?
Common side effects of DEXMEDETOMIDINE HYDROCHLORIDE include Hypotension, Respiratory Depression, Bradycardia, Hypertension, Tachycardia, Nausea.